Make appointment
Portada_hepatitis

Blog

Get the latest news about liver diseases and more

| Diagnosis | Fatty liver
Metabolic syndrome, fatty liver, and their relationship to bile duct cancer

Metabolic syndrome increases the risk of bile duct cancer, especially in patients with fatty liver, where liver disease tends to be more aggressive.

| Fatty liver | News | Treatments
Diuretic drug: Spironolactone and fatty liver

A study shows spironolactone reduces fatty liver risk in patients with hypertension, lowering liver fat accumulation and slowing fibrosis progression.

| Autoinmune hepatitis | Diseases | News
Higher risk of autoimmune hepatitis after age 65

Autoimmune hepatitis incidence has increased notably in older adults, with higher prevalence and better treatment response, often presenting with milder symptoms.

| Fatty liver | Health | Healthy nutrition
How meals and overnight fasting affect fatty liver

A study shows that eating fewer than three times a day and fasting over 14 hours increases fatty liver risk due to circadian rhythm disruption.

| Fatty liver | Health | Healthy nutrition
Low-Carb Diet for Fatty Liver

A study published analyzes the effectiveness of a low-carbohydrate diet in patients with fatty liver disease. Results show weight loss, reduced abdominal circumference, and improvements in liver inflammation and glucose metabolism.

| Health | News
New drugs for weight loss

Orforglipron, an oral GLP-1 small molecule, shows significant weight loss results and may become an alternative to injectable drugs like Ozempic or Wegovy.

| Hepatitis B | News | Treatments
New treatment for Hepatitis B

Hydronidone has demonstrated significant reversal of liver fibrosis in patients with chronic hepatitis B, offering a potential new therapeutic option.

| Fatty liver | News | Treatments
Controlled metabolic accelerator: new drug for treating fatty liver disease

HU6 is a novel oral drug that reduces liver fat and body weight through controlled metabolic acceleration, showing promising results in clinical trials compared to placebo.

1 2 3 … 18
Artículos destacados
Card image cap
Ver más
Card image cap
Ver más
Card image cap
Ver más
Categorías
Card image cap
Hidden infection by C virus

Up to 30% of patients with cryptogenic hepatitis can be caused by the seronegative hidden infection by hepatitis C virus (HIC).

Saber más
Card image cap
Hepatitis A

Hepatitis A is an acute inflammatory disease of the liver, caused by infection with hepatitis A virus (VAH).

Saber más
Card image cap
Hepatitis B

It is a viral infection of the liver that causes inflammation of the liver and the death of hepatocytes.

Saber más
Card image cap
Cholangitis

It is a chronic progressive liver disease that mainly affects women (90% of cases) from the fourth decade of life.

Saber más
Card image cap
Cryptogenic Hepatitis

It is a liver disease of an inflammatory nature and can develop chronically.

Saber más
Card image cap
Hepatitis C

Hepatitis is an inflammation of the liver, and in the case of hepatitis C, caused by infection with hepatitis C virus (HCV)

Saber más
Ver todas

Calle Guzmán el Bueno, 72. 28015 - Madrid

91 544 94 64
91 544 60 13

Open: Monday to Friday
09:00 a 18:00

About Us

The Foundation for the Study of Viral Hepatitis is a benchmark in the field of hepatology worldwide, with the best specialists in liver diseases and molecular biology. A clinic specialized in internal medicine, liver and digestive system in Madrid

Links of interest

Latest Posts

Metabolic syndrome, fatty liver, and their relationship to bile duct cancer

Diuretic drug: Spironolactone and fatty liver

Higher risk of autoimmune hepatitis after age 65
© 2018 - 2026 FEHV Clinic. All rights reserved.  Privacy Policy.  Cookies Policy.  Legal Notice.